By Femtech Insider Breast Health, News, Pharma, Regulatory May 26, 2026 ShareTwitterFacebookPinterest-circled FDA Approves DATROWAY for Triple-Negative Breast Cancer, Delivering Median Survival of Two Years
By Femtech Insider Breast Health, Cancer, News, Pharma May 19, 2026 ShareTwitterFacebookPinterest-circled FDA Approves ENHERTU for Early Breast Cancer in Two New Indications
By Femtech Insider Acquisition, News, Pharma April 28, 2026 ShareTwitterFacebookPinterest-circled Sun Pharma to Acquire Women’s Health Pharma Giant Organon in $11.75 Billion Deal
By Femtech Insider Biotech, Investor, News, Pharma April 9, 2026 ShareTwitterFacebookPinterest-circled European Biopharma Investor Jeito Capital Closes $1.2B Fund
By Femtech Insider Endometriosis, News, Pharma, Research April 1, 2026 ShareTwitterFacebookPinterest-circled Gesynta Pharma Doses First Patient in Phase 2 Trial of Non-Hormonal, Non-Opioid Endometriosis Treatment
By Femtech Insider Endometriosis, News, Pharma March 30, 2026 ShareTwitterFacebookPinterest-circled Hope Medicine Doses First Patient in Phase III Trial of Non-Hormonal Endometriosis Treatment
By Femtech Insider Gynecological Health, News, Partnership, Pharma March 25, 2026 ShareTwitterFacebookPinterest-circled Insilico Medicine and ASKA Pharmaceutical Partner to Discover Novel Drug Targets for Endometriosis, Fibroids and Adenomyosis
By Femtech Insider Breast Health, Cancer, News, Pharma March 20, 2026 ShareTwitterFacebookPinterest-circled Novartis Acquires Next-Generation Breast Cancer Drug in $3 Billion Deal
